Kelly Thomas Patrick | Tormere

Kelly Thomas Patrick

Chief Financial Officer

Chief Financial Officer at Xenon Pharmaceuticals Inc., filing insider transactions on 2026-09-30.

Total Purchases

$560K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1

1 total filings

Active Since

2026-09-30

Last: 2026-09-30

Companies

Xenon Pharmaceuticals Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-30	XENE	Purchase	15.0K	$37.32	$560K	15.0K	SEC ↗